For citations:
Mandrina M.O., Barbolina T.D., Vladimirova L.Yu., Storozhakova A.E., Laktionov K.K. Analysis of the efficiency of integrated chemotherapy in the treatment of patients with non-small cell lung cancer with EGFR L858R mutation in exon 21 using first- and second-generation tyrosine kinase inhibitors. Medical alphabet. 2024;(32):7-13. (In Russ.) https://doi.org/10.33667/2078-5631-2024-32-7-13